evoke pharma stock target

The lowest target is 3636 and the highest is 126. InvestorsObserver is giving Evoke Pharma Inc EVOK an Analyst Rating Rank of 78 meaning EVOK is ranked higher by analysts than 78 of stocks.

Evok Stock Price And Chart Nasdaq Evok Tradingview

Evoke Pharma Target Price Projection Evoke Pharmas current and average target prices are 233 and 1000 respectively.

. EVOK stock analyst estimates including earnings and revenue EPS upgrades and downgrades. The average Evoke Pharma stock forecast 2027 represents a 87684 increase from the last price of 0300000011920929. Evoke Pharma Stock Forecast BUY SELL NASDAQEVOK.

Evoke Pharma Inc NASDAQ. EVOK IEX Real-Time Price USD. Evoke Pharma Inc.

Evoke Pharma Incs upside potential average analyst target price relative to current price is higher than 975 of all US stocks. Evoke Pharma Inc a specialty pharmaceutical company primarily focuses on the development of drugs for. Analysts consensus targets ratings and recommendations Nasdaq.

See Evoke Pharma Inc. Evoke Pharma reported quarterly losses of 7 cents. Evoke Pharmas stock soars 19 premarket after positive FDA product assessment Feb.

Evoke Pharma stock forecast predictions and share price target for 2022 2023 1 year to 2025 - 2027 5 year to 2030 and 2032 10 year with Revenue and EPS Prognosis by Technical Analysis. Whats Up With Evoke Pharmas Stock Popping Off Friday. The Wall Street analyst predicted.

Whats Up With Evoke Pharmas Stock Popping Off Friday. The current price of Evoke Pharma is the price at which Evoke Pharma is currently trading. We Are Well Positioned to Deliver Sustainable Top-Tier Growth Enhanced Shareholder Value.

By Shrey Dua InvestorPlace Assistant News Writer Apr 26 2022 217 pm EDT. HC Wainwright Co. Youll find the Evoke Pharma share forecasts stock quote and buy sell signals belowAccording to present data Evoke Pharmas EVOK shares and potentially its market environment have been in a bullish cycle in the last 12.

Evoke Pharma stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Stock Price Forecast According to 8 stock analysts the average 12-month stock price forecast for EVOK stock is 7956 which predicts an increase of 251711. EVOK analyst stock forecast price target and recommendation trends with in-depth analysis from research reports.

About the Evoke Pharma Inc. Dow Jones a News Corp company About WSJ. EVOKE PHARMA INC.

EVOK is up a jaw-dropping 130 so far on surprising regulatory news. Buy or sell Evoke Pharma stock. The 1 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 3600 with a high estimate of.

That EVOKE PHARMAs share price could reach 1000 by Nov 16 2021. The current Evoke Pharma NASDAQEVOK price target is 000. EVOK shares are trading higher by 231 at 138 after the company reported better-than-expected second-quarter EPS results.

Type Evoke Pharma Medical Companies S. EVOK shares are trading higher by 231 at 138 after the company reported. Analyst ratings historical stock prices earnings estimates actuals.

EVOK updated stock price target summary. Evoke Pharma Inc Stock Market info Recommendations. Year Average Low High Change from close on 2022-06-14.

Price Target Change Rating Change Previous Current Rating. ET by Tomi Kilgore Evoke Pharma shares plunge 75 to pace Nasdaq losers after drug trial. 304 015 519 At close.

15 2017 at 839 am. Wall Street Stock Market Finance report prediction for the future. Evoke Pharma Incs average analyst price target is higher than 1754 of all US stocks.

Evoke Pharma Stock vs. 10 months ago - Benzinga. The number of analysts covering the stock of EVOK is higher than 1307 of Healthcare stocks.

The current Evoke Pharma NASDAQEVOK price target is 000. Evoke Pharma Inc. Find the latest Evoke Pharma Inc.

Learn why top analysts are making this price prediction at MarketBeat. Analyst estimates including EVOK earnings per share estimates and analyst recommendations. Buy or sell Evoke Pharma stock.

Today California-based Evoke Pharma NASDAQ. The average price target for EVOK is 10 and analysts rate the stock as a Strong Buy. As of 2022 June 03 Friday current price of EVOK stock is 2740 and our data indicates that the asset price has been in an uptrend for the past 1 year or since its inception.

On average analysts. Ad Our Strong Track Record Has Enabled Us To Become A Leader In Rare Disease. On the other hand Evoke Pharmas target price is what analysts think the stock is worth or could sell for in the future.

The average price target. - USA Stock USD 026 282 9156 Evoke Pharma stock price prediction is an act of determining the future value of Evoke Pharma shares using few different conventional methods such as EPS estimation analyst consensus or fundamental intrinsic valuation. The average EVOKE PHARMA stock price prediction forecasts a potential upside of 2413 from the current EVOK share price of 293.

Evoke Sluggish Gimoti Launch Creates Need For Massive Dilution Nasdaq Evok Seeking Alpha